资讯

Zacks Small Cap Research on MSN2 小时
AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025
AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported first quarter 2025 results in a May 13th press ...
CAR-T cell therapy is revolutionizing cancer treatment. Here's how it works
Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.